RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • Slide Session : OS-RES-11 ; Tetrahdrobiopterin(BH4): Novel Treatment for Pulmonary Hypertension

        ( Bahaa Francis ) 대한내과학회 2014 대한내과학회 추계학술대회 Vol.2014 No.1

        Background: Pulmonary Hypertension (PH) is characterized by pulmonary vasoconstriction, vascular remodeling, right heart failure and death. The pathogenesis is multifactorial. The integrity of the pulmonary vascular endothelium, particularly its endothelial nitric oxide synthase (eNOS), is a key factor in maintaining normal pulmonary vascular homeostasis. While enzymatically coupled, eNOS produces nitric oxide (NO), otherwise eNOS activation may lead to increased superoxide production. The cofactor tetrahydrobiopterin (BH4) is an important regulator of eNOS function; by ‘recoupling’ eNOS and enhancing its enzymatic activity, BH4 increases NO bioavailability and decreases superoxide production. Thus pharmacological supplementation with BH4 may be a novel treatment in PH. Methods: Isolated perfused lung studies were used to explore the acute pharmacological effects of BH4 in regulating pulmonary vascular tone. Animal studies were used to evaluate the pharmacological effects of BH4 treatment and to clarify its molecular mechanism using biochemical and histological experiments. Results: In acute ex-vivo studies, BH4 was found to regulate hypoxic pulmonary vasoconstriction. Its effects are mediated via enhancing NO and H2O2 secretion and its antioxidant properties, all leading to pulmonary vasodilation. Superoxide dismutase co-administration with BH4 enhanced its vasodilatory effect. In chronic studies, BH4 prevented the development of PH in monocrotaline model and ameliorated established PH when administered to recover the disease. BH4 partially reversed PH in hypoxia model. In both models, BH4 reduced pulmonary vascular muscularization and reversed right ventricular hypertrophy. BH4 effect was evidenced by enhancing the activity and protein levels of eNOS, recoupling eNOS activity to produce more NO, and its second messenger cGMP, and lowering the levels of superoxide. Conclusions: BH4 bioavailability is essential for maintaining pulmonary vascular homeostasis, and plays a major role in the pathophysiology of PH. This study establishes a fi rm basis to explore the therapeutic potential of BH4 in human PH.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼